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Harsh self-criticism not only triggers strong negative emotional
responses but also is a symptom of depression itself. Accordingly,
pervasive self-critical thinking is considered to be a risk factor
for the development and maintenance of depression,1 and
is consequently an important psychotherapeutic target.2
Cognitive–behavioural therapy (CBT) is an empirically supported
intervention that is efficacious in the acute treatment of major
depressive disorder in 40–60% of patients. Hence, depending on
patient and therapy characteristics, a large proportion of patients
still fail to achieve an adequate response.2
The identification of neural abnormalities in depression
during self-critical processing and the search for related neuro-
physiological markers of outcome prediction might advance
differential treatment selection. In this study we examine the
potential psychological mechanisms linking neural markers to
psychotherapy outcomes. This integrative neurophysiological–
psychological strategy might help to optimise individualised
treatment strategies for patients with depression. Major depressive
disorder is characterised by disturbances in emotional processing.
In processing emotional stimuli, the amygdala functions by
mediating attention, assigning an evaluation to the emotional
stimulus and storing emotionally significant events in long-term
memory. Additionally, the amygdala has numerous connections
with other brain regions, such as the ventral striatum, which
further process and integrate emotional information.3 Previous
studies have reported depression-related hyperactivity in the
amygdala as well as in the ventral striatum,4,5–9 probably causing
negatively biased emotion processing, for instance in the
evaluation and judgement of emotional stimuli. The majority of
related functional magnetic resonance imaging (fMRI) studies
have used standardised emotional pictures, masked or unmasked
facial stimuli or personally relevant rating tasks for examining
neural responses to emotional stimuli. However, using standardised
emotional paradigms, several authors also reported no difference
in amygdala activity between patients with depression and a
control group (see Townsend et al for an overview).10 In contrast,
the few studies using specific and personally relevant emotional
stimuli have reported robust enhanced activation of striatal
regions and the amygdala in people with acute depression,8,11,12
as well as in patients with a history of depression confronted
with critical comments about their own mothers.13 Moreover,
passive processing of emotional visual stimuli is associated with
a higher probability of amygdala activation than processing
accompanied by active task instructions.14 A previous study has
shown enhanced amygdala activity during confrontation with
individualised self-critical stimuli compared with neutral stimuli
in a healthy sample.15 Accordingly, methodological heterogeneity
regarding individualisation of stimuli and mode of presentation
may explain some of the mixed findings, in addition to sample
differences in symptom profiles, medication status, levels of
depression severity or comorbid anxiety disorders.10 Consequently,
the method chosen in our study – examining abnormal responses
of the amygdala and ventral striatum to individualised, painful
self- critical stimuli in an unmedicated patient sample with
depression using the technique of passive exposure to stimuli –
promises to yield more ecologically valid and robust results.
Functional magnetic resonance imaging assessment has been
suggested as a powerful strategy for identifying prognostic
markers of clinical response.16 Using a meta-analytic approach,
Fu et al found enhanced activity in the right striatum and anterior
insula to be associated with a lower likelihood of clinical benefit
from treatment including CBT and medication.16 However,
previous studies of amygdala response have yielded heterogeneous
results regarding outcome prediction. Related findings have
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indicated increased baseline amygdala activation in those who
subsequently responded to therapy but have also shown the
reverse relationship, with increased amygdala activity associated
with poor outcomes during the treatment of depression and
post-traumatic stress disorder (PTSD).17 Moreover, several studies
have reported no significant relationship between amygdala
activity and outcome (see Fu et al for an overview).16
In accordance with the results of studies using individualised
emotional stimuli, we predicted enhanced response in the
amygdala and ventral striatum in patients with depression
compared with a matched healthy control group. In addition,
we explored differences between those who did and did not
respond to therapy, as well as the potential prediction of treatment
outcome by differences in amygdala and striatal activity. If such
predictions were verified we aimed to explore the associated
psychological change mechanisms, defined as therapeutic
processes that have the potential to ameliorate psychopathological
disorder.18 Among other factors, change in dysfunctional
cognition as well as the acquisition of emotional skills have been
identified as psychological change mechanisms that are associated
with better CBT outcomes.19,20 Consequently, we set out to
examine whether the potentially identified biomarker–outcome
relationships would be mediated by changes in dysfunctional
cognitions and/or by acquisition of emotional skills.
Method
We investigated a sample of patients with a current major
depressive episode (MDE; n= 23) and a control group of healthy
individuals (n= 28). All participants were right-handed, native
German speakers and showed no contraindication to MRI. The
study procedure was approved by the local ethics committee,
and all participants provided advance written informed consent.
Treatment was free of charge, and participation in the fMRI
assessment was reimbursed according to local standards. Patients
were recruited from a larger study of cognitive–emotional
processing in psychotherapy. The fMRI data of six control group
participants had been analysed for a previous publication.15
To qualify for the study, patients were required to have a
minimum score of 14 on the Beck Depression Inventory II
(BDI-II) at screening.21 Average depression severity at baseline
was moderate, with a mean BDI-II score of 26.6 (s.d. = 9.3).
Diagnoses of MDE were confirmed with the Structured Clinical
Interview for DSM-IV.22 Exclusion criteria included a history of
mania or psychotic symptoms; borderline, antisocial or schizotypal
personality disorder; and current substance dependence. In total,
24 persons with major depressive disorder were scanned. One
person was excluded from further study owing to lack of
motivation and strong discomfort during the scan. Thus, the data
for 23 patients (11 women; mean age 37.4 years, s.d. = 17.1) were
included. Most of the patients (70%) were diagnosed with a
recurrent MDE (1 patient with one previous episode, 11 patients
with two to five episodes and 3 patients with more than five
previous episodes; 1 missing data), whereas the remaining 30%
met criteria for a first MDE. Other comorbid diagnoses, including
anxiety disorders (39%), were acceptable as long as depression was
the primary treatment focus. The patients did not take any
psychotropic medication for at least 4 weeks prior to the scan
sessions and remained medication-free throughout the treatment
and 3-month follow-up period. Fifteen patients were medication-
naı¨ve, and six patients had taken selective serotonin or serotonin–
noradrenaline reuptake inhibitors before the study (5 patients
stopped more than 4 years before the study began, 1 patient
stopped 1 year before). Additionally, one patient took a tricyclic
antidepressant (stopped 1 year before the study) and for one
patient we have no further information about medication intake
prior to the study beyond the required 4 weeks. Healthy
participants in the control group had no personal or first-degree
relative history of major depressive disorder and no self-reported
psychiatric problems (13 women; mean age 35.6 years, s.d. = 12.6).
The two study groups did not differ in age (P= 0.60), gender
distribution (P= 0.92), marital status (P=0.44) or highest level
of education (P= 0.17).
After comparing the neural activity of the healthy participants
with that of the participants with depression, we further compared
brain activity at baseline between those who did or did not
respond to CBT, and studied eventual links with therapy
outcomes. Two patients withdrew before completing the 22
therapy sessions (sessions 15 and 19) and were not included in
the longitudinal analysis. The resulting patient sample comprised
21 participants (10 women; mean age 38.3 years, s.d. = 12.4).
Another three patients had missing data at follow-up.
Psychometric measures
Symptom severity in the group with depression was measured
using the German version of the 21-item BDI-II.21,23 For the
assessment of emotion regulation skills we used the total score
of the 27-item German version of the Emotion Regulation Skills
Questionnaire (ERSQ).24 Dysfunctional cognitions were assessed
using the 40-item German version of the Dysfunctional Attitude
Scale (DAS).25 To control for trait anxiety we used the 20-item
trait form of the State–Trait Anxiety Inventory (STAI).26
Procedure
Psychotherapy was offered as a research therapy separate from
routine care in the out-patient clinic of the University of Zurich’s
psychology department. In total, 15 different therapists (2 men, 13
women) conducted the treatments, each treating one or two
patients. All patients were scanned before the onset of their 22
weekly individual CBT sessions. Depressive symptoms were
assessed before therapy at baseline (pre-treatment), directly after
therapy ended (post-treatment) and 3 months later (follow-up).
We defined response to treatment a priori as a minimum pre- to
post-treatment reduction of 50% in BDI-II scores, on the basis
of a previous study comparing pre-treatment brain response to
fearful and neutral facial expressions and response to CBT in
PTSD.17 Furthermore, a validation study of response and
remission criteria reported that response best corresponded to a
BDI change of 47%, showing a sensitivity of 80% and a specificity
of 67%.27 Moreover, among self-report measures, the BDI-II has
achieved wide acceptance and is sensitive to change.23 Assessments
with the ERSQ and the DAS took place both immediately prior to
and after treatment. Trait anxiety was assessed at baseline.
Stimuli and task
During the fMRI measurement, participants were presented with
three different types of adjectives in six 29 s blocks of four
adjectives each: neutral adjectives, individualised self-critical
adjectives and individualised negative adjectives that were not
self-critical. Furthermore, six 29 s blocks of rest (looking at a
fixation cross) were inserted randomly. Each block contained an
introduction indicating the condition (neutral, negative, self-
critical) followed by the presentation of the four adjectives and
a request to press a button. In this paper we show only analyses
of the neutral and self-critical conditions. Figure 1 shows the
presentation times for a self-critical and a neutral block. For each
person we ran one session lasting approximately 12min. The
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order of presentation was completely randomised and differed
between participants. Neutral adjectives were the same for all
participants and were pre-selected by the authors from 100
potentially neutral words. Forty-two volunteers (21 women and
21 men) rated the valence of all adjectives using a scale ranging
from 72 (very negative) to +2 (very positive). Twenty-four
adjectives were selected with modal values of 0 and mean values
between 70.2 and 0.2. Individualised self-critical and negative
non-self-critical blocks consisted of prototypes (e.g. fat, boring,
jealous) that participants chose individually from a list of 52
negative attributes. During the imaging experiment prototypes
were presented interspersed with their three respective synonyms
that were chosen based on a German word database (http://
wortschatz.uni-leipzig.de) and assumed to activate the same self-
schema. All stimuli consisted of one to three syllables and at least
12 letters. We made sure that all adjectives reached a frequency
level of at least 20 according to the Leipzig Word Database
(frequency level based on Zipf ’s law, which states that the
reference word ‘the’ (‘der’) is 2^20 times more frequent than
the respective word, ensuring common use in everyday language).
Participants were instructed to read the adjectives silently and
focus on their meaning as well as on the triggered emotional
reactions. For more details about the stimuli and their assessment
see our previous study.15
Imaging
The fMRI scanning took place at a university psychiatric hospital
in Switzerland using a 3 T Philips Intera whole-body MR unit
equipped with an 8-channel Philips sensitivity-encoding (SENSE)
head coil (www.healthcare.philips.com). Functional time series
were acquired with a SENSE single-shot echoplanar imaging
sequence.28 Thirty-six contiguous axial slices were placed along
the anterior–posterior commissure plane covering the entire brain.
A total of 247 T2*-weighted echoplanar image volumes with blood
oxygen level-dependent (BOLD) contrast (repetition time
3000ms, echo time 35ms, 8080 voxel matrix, interpolated to
1286128, voxel size 2.7562.7564mm3, SENSE acceleration
factor R=2.0) were acquired. The first four scans were discarded
owing to T1 saturation effects. For each participant a T1-weighted
high-resolution image was acquired.
Data preprocessing and statistical analysis
The functional image data were preprocessed and analysed in
SPM8 (www.fil.ion.ucl.uk/spm) and implemented in MATLAB
R2011a (Mathworks, Natick, Massachusetts, USA) using standard
preprocessing steps.29 First-level analysis (fixed effects) was
performed on each participant’s data including the six movement
regressors and the three condition regressors. The BOLD data
were modelled with a block design convolved with the standard-
ised canonical haemodynamic response function and its temporal
derivative. Estimated beta parameters and t-contrast images were
brought to the second-level analysis (random effects). For both
fMRI data group analyses (patients v. controls; response v. non-
response), images of the contrast of interest (self-critical v.
neutral) were analysed using two-sample t-tests. A voxel-wise
threshold of P50.001, requiring more than 10 contiguous voxels,
was applied. According to our a priori hypotheses, we reported
amygdala and striatal structures significant at P50.05 family-wise
error corrected at the cluster level after small volume correction
(SVC) in SPM using the bilateral anatomical masks created with
the WFU Pickatlas toolbox (www.fil.ion.ucl.ac.uk/spm/ext/). All
coordinates are reported in Montreal Neurological Institute
(MNI) space and peak activations were labelled according to the
Anatomical Automated Labeling atlas implemented in SPM
(www.fil.ion.ucl.ac.uk/spm/ext/). Analyses of sociodemographic
data (w2-tests) were performed to ascertain comparability of
the two respective groups. Furthermore, as structural volume
differences of the amygdala might affect the findings of the
cross-sectional analyses, we further ran SVC analysis integrating
grey-matter volumes for each participant as a covariate vector of
the left and right amygdala separately (see online supplement
DS1 for the structural MRI data acquisition and voxel-based
morphometry).
To examine change in depressive symptoms independent of
initial severity, residual gain scores were calculated from a
regression of pre-treatment BDI-II scores on post-treatment and
follow-up scores.17 Associations of possible predictors and
outcome were analysed using Pearson correlations (two-tailed)
between the BOLD signal extracted from 6mm radius spheres
around peak voxels from the responder-analysis and residual
BDI-II gain scores at post-treatment and follow-up. Mean beta
parameter estimates were extracted using a MATLAB script
programmed in-house.
Mediation analyses were calculated using the PROCESS script
by Preacher & Hayes.30 The total effect (c) of an independent
variable on a dependent variable is composed of a direct effect
(c ’) and an indirect effect through a proposed mediator. The
indirect effect was computed by bootstrapping re-sampling with
1000 samples. We considered point estimates of the indirect effects
as significant in case zero was not included in the 95% confidence
interval. We used residual BDI-II gain scores at post-treatment
and follow-up as dependent variables. Potential mediator variables
were residual DAS and ERSQ gain scores, reflecting changes in
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cognitive and emotional processes during therapy. Correlation
and mediation analyses were performed in PASW Statistics version
18.0 (IBM, Switzerland).
Results
Cross-sectional analyses
In accordance with our hypotheses, participants with major
depressive disorder showed enhanced activity in the left amygdala
(coordinates: 722, 76, 716; t49 = 4.05, k= 21), the bilateral
putamen (right: coordinates 36, 0, 74; t49 = 4.13, k= 31; left:
coordinates 732, 710, 4; t49 = 3.93, k=20) and two clusters in
the right caudate nucleus (coordinates 6, 12, 72; t49 = 4.63,
k= 80; coordinates 20, 26, 0; t49 = 4.09, k=14), surviving SVC at
P<0.05. Significant voxels in the right amygdala (coordinates 30,
2, 716; t49 = 3.62, k=4) did not reach our predefined cluster size
(k410). Moreover, separate SCV analyses for each hemisphere
including the mean amygdala grey matter volumes of the
respective hemispheres as covariates were performed. As described
in online supplement DS1, we had to exclude three healthy
individuals from these analyses because of the poor quality of
the structural data. Small volume correction analyses resulted in
significant differences for the left (t= 4.74, P=0.004, k= 54) and
right hemispheres (t=4.16, P=0.014, k= 13). Cortical group
differences at the whole-brain level are reported in online
Table DS1.
Prediction analyses
Clinical response
We divided those who completed therapy (n=21) into two
groups: those who responded to treatment (n=13) and those
who did not (n=8) (Table 1). Figure 2 shows the distribution
of the patients as well as assignments to the respective groups. At
baseline there was no statistically significant difference between the
two groups regarding gender distribution (P=0.86), age (P=
0.98), marital status (P=0.63), highest educational level (P=0.22),
single or recurrent episodes (P=0.75), chronicity (P=0.92) or
comorbid anxiety disorder (P=0.60). There was no significant
difference on any of the assessed measures at baseline between the
groups, but there were significant differences at post-treatment for
the BDI-II and the ERSQ (Table 1).
Differences in brain activity
The non-responder and responder groups differed only in the
right amygdala (coordinates 26, 2, 720; t19 = 4.30, k= 19), with
the non-responder group showing enhanced activity, surviving
SVC at P40.05 (Fig. 2(a,b)). Because amygdala activity might
be related to depression severity or to anxiety,31,32 we included
in a further step BDI-II pre-treatment score, trait anxiety or
comorbid anxiety as covariates of interest in the between-group
analysis. This affected the results only slightly (online Table
DS2). No difference in the activation of striatal regions was
detected. Moreover, the responder group did not show higher
activity in any region compared with the non-responder group.
Baseline neural activity and treatment response
The BOLD response in the right amygdala during confrontation
with self-critical material correlated positively with residual BDI-II
gain scores at post-treatment (n=21; r=0.52, P=0.02) (Fig. 2(c))
and follow-up (n=18; r=0.53, P=0.02). Therefore, poor response
to CBT was significantly associated with increased right amygdala
recruitment during the processing of self-critical material.
Mediation analysis
To explain the association between amygdala activity and negative
outcome in CBT, we evaluated the change in dysfunctional
cognition and in emotional skills as theoretically derived and
empirically supported mechanisms of change that might be
compromised by amygdala hyperactivity. In the related mediation
analysis, the association between right amygdala activity before
therapy and residualised depression scores post-therapy was
mediated by emotional skill acquisition. After controlling for this
acquisition the relation between amygdala activity and outcome
was no longer significant, indicating full mediation (Table 2). This
effect survived introduction of comorbid anxiety and/or trait
anxiety as covariates. Furthermore, we found similar mediation
effects when the residual BDI-II gain score at follow-up was the
dependent variable (n= 18). The replacement of missing data at
follow-up using a last observation carried forward approach by
integrating post-treatment measurement data for three patients
revealed comparable effects (online Table DS3). In contrast, there
was no mediation by change of dysfunctional attitudes at post-
treatment and follow-up (Table 2). Online Fig. DS1 shows the
mediation path model.
Discussion
We examined the role of amygdala and striatal response after
confrontation with individualised self-critical stimuli in unmedicated
patients with depression and healthy control participants.
Additionally, the potential of these subcortical activations as
biomarkers of CBT outcome prediction in concert with likely
psychological change mechanisms was investigated.
Patients v. healthy participants
In accordance with our hypothesis and with previous findings,
patients showed enhanced activity compared with control
participants in the amygdala and the bilateral ventral striatum
(bilateral putamen and caudate nucleus) after emotional
activation, which potentially indicates an altered neural circuitry
involved in emotion processing.3,8 Our results therefore further
support the use of more ecologically valid task designs using
individualised stimuli for the study of abnormal subcortical
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Table 1 Psychometric data for the sample before receiving
cognitive–behavioural therapy and at post-treatment and
3-month follow-up
Score, mean (s.d.)
Responder group
(n=13)
Non-responder group
(n=8) P
BDI-II
Pre-treatment 27.85 (8.44) 26.13 (10.39) 0.68
Post-treatment 6.23 (5.54) 21.25 (7.19) 50.001
Follow-up 8.30 (7.62)a 19.75 (15.00) 0.05
ERSQ
Pre-treatment 79.36 (12.38) 71.13 (13.30) 0.16
Post-treatment 109.12 (12.54) 75.88 (14.97) 50.001
DAS
Pre-treatment 148.36 (24.13) 131.25 (31.04) 0.17
Post-treatment 128.64 (28.60)b 137.20 (23.81) 0.50
STAI Trait
Pre-treatment 60.01 (9.62) 56.131 (12.63) 0.42
BDI-II, Beck Depression Inventory II; DAS, Dysfunctional Attitude Scale; ERSQ, Emotion
Regulation Skills Questionnaire; STAI, State–Trait Anxiety Inventory.
a. n=10.
b. n=12.
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responses in people with an MDE. At the cortical level we found
enhanced activity in patients with an MDE in a distributed
network of the bilateral occipital cortex, mainly in higher-order
visual areas, extending to the bilateral fusiform gyrus. In the left
hemisphere, activations expanded into the temporal cortex.
Converging evidence from both animal and human research
suggests emotion- and attention-related modulation of visual
processing. Emotional induction using visual stimuli probably
activates the occipital cortex and enhanced activity in these
regions might be driven by hyperactivity of the amygdala, which
has strong anatomical connections to visual areas.33,34
Response v. non-response
Participants who did not respond to therapy showed increased
neural activity in the right amygdala during confrontation with
self-critical material when compared with those who did respond.
In addition, brain activity in this region correlated negatively with
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Fig. 2 Right amygdala activity. (a) Enhanced activity in the right amygdala in the non-responder group compared with those responding
to therapy (P50.001, k410). (b) Plotted mean beta parameter estimates (eigenvariates) and standard errors of contrast images (self-critical
v. neutral) in the responder group (blue) and the non-responder group (white). (c) Relationship between right amygdala activity (beta
parameter estimates) and z-standardised residual gain scores on the Beck Depression Inventory post-treatment.
Table 2 Summary of mediation analyses
Standardised regression coefficient (b)
Independent
variablea
Mediating
variableb
Dependent
variableb
Effect of IV
on MV (a)
Effect of MV
on DV (b)
Direct
effect (c’)
Indirect
effect (ab)
Total
effect (c) n
Amygdala activity ERSQ BDI-II post 70.54** 70.56* 0.19 0.30c 0.52* 21
Amygdala activity ERSQ BDI-II follow-up 70.55* 70.62** 0.16 0.34c 0.53* 18
Amygdala activity DAS BDI-II post 70.01 0.61** 0.51** 70.006 0.50* 20
Amygdala activity DAS BDI-II follow-up 0.10 0.35 0.44 0.04 0.50 17
BDI-II, Beck Depression Inventory II; DAS, Dysfunctional Attitude Scale; DV, dependent variable; ERSQ, Emotion Regulation Skills Questionnaire; IV, independent variable; MV, mediating
variable.
a. Amygdala activity: mean beta values of 6mm right amygdala sphere.
b. Residualised gain scores.
c. Significant point estimate (P50.05).
*P50.05, **P50.01.
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CBT outcome. These results indicate that there might be a
subgroup of patients with MDE with enhanced amygdala activity
in response to emotional stimuli, predicting poorer CBToutcome.
Ruling out alternative explanations of the observed differences
between the responder and non-responder groups, these groups
did not differ in terms of gender distribution, age, marital status,
highest educational level, single or recurrent episode, chronicity,
comorbid anxiety disorder or baseline symptom severity. The last
suggests that amygdala hyperactivity may be more than a marker
of severe depression. Therefore, future research should examine
the risk factors of insufficient treatment response such as
depression subtypes, personality factors or genetics that are
associated with elevated amygdala response in more detail.
Remarkably, Bryant et al reported a similar association between
amygdala activity at baseline and insufficient treatment response
in patients with PTSD,17 raising the question whether amygdala
hyperreactivity may be a transdiagnostic risk factor for therapy
non-response. In support of this notion, a recent meta-analysis
reported an association between increased activation in the right
amygdala, striatum and insula and an increased likelihood of poor
response to antidepressant medication.16
Mechanisms of change
Mediation analyses showed that the negative relationship between
right amygdala activation and change in depressive symptoms
during therapy might be explained by improvement of emotion
regulation skills. Given that there was no mediation for change
in dysfunctional attitudes, the specificity of this finding for
emotional changes is highlighted.35 Considering these results, we
propose that high levels of amygdala activation by individualised
self-critical stimuli at baseline may hamper patients’ readiness to
learn new emotion regulation skills. In support of this hypothesis,
a recent study demonstrated that adding emotion regulation
training to CBT for depression given as an in-patient treatment
improved treatment outcome.36
Study implications and limitations
To our knowledge this is the first study to examine the potential
change mechanisms underlying a biomarker–outcome association.
At this point it would be premature to derive clinical
consequences from these results, as replication of the findings will
be necessary. However, the findings may add to the quest for
tailored treatment strategies by uncovering a subgroup of patients
with depression with amygdala hyperactivity possibly benefiting
from initial training in emotion regulation skills before engaging
in emotionally challenging interventions in the course of
psychotherapy. As an alternative to compensating for skill deficits,
therapists might additionally search for individual strengths to
build on when dealing with challenging emotions, such as
memories of previously mastered challenges or interpersonal
resources. Along these lines, a study has reported better outcomes
in personalising treatment to patients’ relative strengths than to
their relative deficits.37 Whereas our study identified a possible
link between neural activity at baseline and a psychological
mechanism of change, it is still unclear exactly how amygdala
hyperactivity might impede the development of emotion regulation
skills. One explanation might be that overly strong emotions are
experienced as disturbing and overwhelming, and consequent
avoidance of displeasing emotions might impede or even prevent
emotional change. In any case, before deducing practical
implications it would be necessary to gain more information
about factors potentially interconnecting amygdala hyperreactivity,
impeded development of emotional skills and treatment outcome.
A main limitation of our study was the lack of a no-treatment
control group. As a consequence, we were not able to exclude the
possibility that the observed correlation of amygdala hyperactivity
and non-response might have resulted from more general effects
occurring in psychotherapy as well as in drug treatment, such as
time- and/or placebo effects. Another important limitation of
the study is its small sample size; our results must therefore be
regarded as strictly preliminary. An additional limitation may be
that we did not systematically assess negativity ratings of the
neutral words during or after the scan. Given the negativity bias
of people with depression, this might have had an influence on
the self-critical v. neutral contrast that we could not control.
Optimally, negativity ratings should be assessed immediately after
presentation during the scan. However, as this would imply
introducing a significant cognitive component potentially
interfering and decreasing activation in limbic regions, we
refrained from this option. Future studies might assess negativity
bias using post-scan ratings. Methodologically, we recommend the
use of in-session assessments of emotion processing and
emotional change in psychotherapy to clarify further the
associations between process–outcome relationships and neural
predictors. Nevertheless, this interdisciplinary research strategy
holds great promise for tailoring the treatment of patients with
depression in the service of better outcomes.
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Data supplement to Doerig et al. Amygdala response to self-critical stimuli and 
symptom improvement in psychotherapy for depression. Br J Psychiatry doi: 
10.1192/bjp.bp.114.149971 
 
DS1 Structural MRI data acquisition and voxel-based morphometry 
Structural MRI data acquisition 
Images were acquired on a Philips Achieva 3 Tesla whole-body MRI unit equipped with an 
eight-channel head coil using a sensitivity encoded single shot echo-planar sequence (SENSE, 
acceleration factor R=2). A T1-weighted gradient echo sequence (turbo field echo) with a 
spatial resolution of 0.94×0.94×1.00 mm3 (matrix: 240×240 pixels; 160 slices), field of 
view=240×240 mm2, echo time (TE)=3.7 ms, repetition time (TR)=8.06 ms, flip angle=8° 
was applied.  
Voxel-based morphometry 
Structural images were analyzed using voxel-based morphometry (VBM 8) toolbox 
(http://dbm.neuro.uni-jena.de/vbm8/) using default parameters and employing a 
Diffeomorphic Anatomical Registration Through Exponentiated Lie algebra approach 
(DARTEL),38 from the statistical parametric mapping software (SPM8; http://www.fil.ion.ucl. 
ac.uk). Images were bias-corrected, tissue classified, and normalized to MNI space using 
linear (12-parameter affine) and nonlinear transformations, within a unified model,39 
including high-dimensional DARTEL normalization. GM and WM segments were modulated 
only by the nonlinear components to preserve actual GM and WM values locally (modulated 
GM and WM volumes). Homogeneity of GM and WM images was checked using the 
covariance structure of each image with all other images, as implemented in the check data 
quality function. Based on these results, three healthy subjects were excluded from the group 
analysis because mean covariance for data was below 2 standard deviations. Patient and 
control groups did not differ in age (P=.54), sex distribution (P=.10), marital status (P=.46), 
or highest level of education (P=.20). The modulated GM images were smoothed with a 
Gaussian kernel of 8-mm full-width-at-half-maximum. The left and right amygdala masks 
were defined from the wfupickatlas/aal from the SPM toolbox and mean GM volumes across 
these masks were calculated using MarsBaR (http://marsbar.sourceforge.net/) from the SPM 
toolbox. 
References 
38. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007; 
38: 95-113. 
39. Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005; 26: 839-51. 
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Table DS1: Cortical brain areas with enhanced activity in MDE patients compared to 
control participants for the contrast self-critical>neutral 
Anatomical 
region 
Hemisphere Cluster 
size (voxel) 
t (df 49) P corrected 
Cluster-
level 
MNI coordinates 
x y z (mm) 
Fusiform  Right 236 4.47 0.040 40 -54 -18 
 Right  4.46  40 -44 -18 
 Right  3.62  30 -62 -16 
Occipital 
inferior  
Left 1632 5.98 <0.001 -28 -76 -6 
Fusiform  Left  5.70  -36 -58 -16 
 Left  4.72  -36 -44 -12 
Precentral  Right 246 4.74 0.027 46 -6 42 
 Right  3.32  42 -2 56 
Cuneus Right 412 4.29 0.004 20 -68 36 
Occipital 
superior 
Right  3.69  28 -78 20 
Occipital 
middle 
Right  3.67  32 -68 16 
Note. Clusters significant at P<0.001 (κ>10) on whole brain level after statistical correction (FWE correction at cluster level, 
P<0.05) are reported. Multiple peaks within the same label are shown on subsequent lines. Regions are labeled according to 
the AAL-atlas. 
 
Table DS2: Details of the responder analysis including covariates 
Covariate (pre) Anatomical 
region 
MNI 
coordinates  
x y z (mm) 
t (df 18) Cluster size 
(voxel) 
BDI-II Right Amygdala 24, 2, -20 4.12 22 
STAI trait Right Amygdala 26, 0, -22 4.65 40 
Comorbid anxiety Right Amygdala 26, 0, -22 4.80 38 
Note. Clusters significant at P<0.001 unc. (κ>10). Regions are labeled according to the AAL-atlas. 
 
Table DS3: Mediation analyses (last observation carried forward). 
Independent 
variable 
(IV) 
Mediating 
variable 
(M) 
Dependent 
variable 
(DV) 
Effect of 
IV on M 
(a) 
Effect of 
M on DV 
(b) 
Direct 
effect (c’) 
Indirect 
effect (ab) 
Total 
effect (c) 
 
N 
 
Amygdala 
activity ERSQ 
BDI-II 
follow-up β = -.54** β = -.80** β = -.05 β = .43
a β = .53* 21 
Amygdala 
activity DAS 
BDI-II 
follow-up β = -.01 β = .37 β = .51* β = -.004 β = .51* 20 
Note. Amygdala activity = mean beta values of 6 mm right amygdala sphere, M and DV = residualized gain scores. β = 
standardized regression coefficients. *P<.05. **P<.01. a Significant point estimate (P<.05). BDI-II data of three patients at 
follow-up replaced with data at post using last observation carried forward technique. 
  
 3 
Fig. DS1: Mediation path model. 
 
 
Figure DS1. Mediation path model of right amygdala activity (mean beta values), residual symptom severity post and 
emotional-skill acquisition. Standardized regression coefficients (β) for the direct (A) and the indirect (B) paths are given. 
*P<.05. **P<.01. 
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